It is no longer a rare sight to see a biotech file for bankruptcy but it still raises the eyebrows when a firm established nearly 30 years ago which had a significant degree of success such as Acorda Therapeutics, Inc. goes out of business.
After cancelling its fourth-quarter conference call at the last minute, Acorda has filed for Chapter 11 bankruptcy protection following a...